2025 - Introduced
Massachusetts H.1134/S.863
  • Mandates Medicaid from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioid drugs. The bill also creates a comprehensive integrated care management strategy for chronic pain patients enrolled in Medicaid and requires the Center for Health Information & Analysis to issue a report every two years on the incidence and prevalence of chronic pain in Massachusetts.
Medicaid Parity
Read House BillRead Senate Bill
2025 - Introduced
Michigan S.B. 551
  • Prohibits Michigan Medicaid from disadvantaging or discouraging a non-opioid drug on the states preferred drug list with respect to coverage of an opioid drug, including through more restrictive coverage criteria or utilization management.
  • Requires Michigan's Medicaid program to cover at least one non-opioid drug for pain management on the preferred drug list.
Medicaid Parity
Read Bill
2025 - Introduced
Minnesota S.F. 1947/H.F. 1807
  • Requires that in establishing and maintaining Minnesota's preferred drug list, health insurers must not disadvantage or discourage a non-opioid drug with respect to coverage of an opioid drug.
Medicaid Parity
Read Senate BillRead House Bill
2025 - Introduced
Mississippi H.B.1389
  • Prohibits practices that disadvantage or discourage the use of non-opioid drugs relative to opioids in state Medicaid program.
Medicaid Parity
Read Bill
2025 - Introduced
Montana H.B. 774
  • Prohibits Medicaid and health insurers from denying coverage of a non-opioid in favor of an opioid and requires that in establishing a drug formulary, the Montana Department of Public Health and Human Services must ensure a non-opioid is not disadvantaged or discouraged as compared to coverage of an opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Nebraska L.B. 252
  •  Prohibits Medicaid and commercial health insurers from disadvantaging or discouraging a non-opioid drug with respect to coverage of an opioid drug.
Medicaid Parity
Read Bill
2025 - Introduced
Nevada S.B. 377
  • Requires health insurers and Medicaid cover at least one alternative to an opioid and prohibits insurers from requiring prior authorization or other restrictive requirements for an alternative to an opioid compared to requirements established for an opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2024 - Introduced
New Jersey A4682
  • Prohibits health insurers, Medicaid and School Employees’ Health Benefits from denying coverage of non-opioid prescription drugs in favor of opioid prescription drugs. Further, formularies are prohibited from disincentivizing the use of non-opioids with respect to coverage or cost-sharing.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2024 - Passed
Oklahoma S.B.1344
  • Requires that the state Medicaid preferred drug list and utilization management not disadvantage a non-opioid pain medication relative to an opioid pain medication.
  • Requires the state government to seek grant opportunities relating to education and services regarding non-opioid medications.
  • Provides that the state may assist in using opioid settlement funds to support education regarding non-opioid alternatives.
Medicaid ParityEducation
Read Bill
2025 - Introduced
Oregon S.B.598
  • Requires health insurers and Medicaid establish parity for opioids and non-opioid treatments.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
South Carolina S.B. 161/H.B. 4165
  • Prohibits preferencing coverage of an opioid prescription treatment over a non-opioid treatment and requires the South Carolina Department of Public Health to create educational materials and guidelines for practitioners about non-opioid alternative treatment options.
Medicaid ParityEducation
Read Senate BillRead House Bill
2025 - Introduced
South Dakota H.B.1137
  • Ensures FDA-approved non-opioid drugs are not disadvantaged or discouraged with respect to coverage of an opioid on the state preferred drug list.
Medicaid ParityState Regulated Commercial Parity
Read Bill